Cargando…

Inhibition of BRD4 enhanced the tumor suppression effect of dasatinib in gastric cancer

BRD4, a member of the bromodomain and extraterminal (BET) family, is elevated in multiple cancer tissues, including gastric cancer (GC). Targeted therapy with BRD4 may help improve the overall survival of patients with GC. Meanwhile, the approved multi-target kinase inhibitor, dasatinib, was recentl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Hao, Hu, Xuefei, Yang, Xinrui, Chen, Jiahui, Fu, Yating, He, Hongwei, Shi, Yongkang, Zeng, Rong, Chang, Wenjun, Zheng, Shangyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646567/ https://www.ncbi.nlm.nih.gov/pubmed/36352160 http://dx.doi.org/10.1007/s12032-022-01831-8

Ejemplares similares

SHP2 inhibition improves celastrol-induced growth suppression of colorectal cancer
por: Zhang, Linxi, et al.
Publicado: (2022)

Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma
por: Li, Ye, et al.
Publicado: (2021)

Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
por: Li, Gong-Quan, et al.
Publicado: (2015)

Ubenimex enhances Brd4 inhibition by suppressing HEXIM1 autophagic degradation and suppressing the Akt pathway in glioma cells
por: Han, Liping, et al.
Publicado: (2017)

Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression
por: Tan, Yifan, et al.
Publicado: (2018)

Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury
por: Kim, Areumnuri, et al.
Publicado: (2020)

Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1
por: Xu, Li, et al.
Publicado: (2017)

BRD7 inhibits enhancer activity and expression of BIRC2 to suppress tumor growth and metastasis in nasopharyngeal carcinoma
por: Li, Mengna, et al.
Publicado: (2023)

BRD9-mediated chromatin remodeling suppresses osteoclastogenesis through negative feedback mechanism
por: Du, Jiahui, et al.
Publicado: (2023)

DSC2 Suppresses the Metastasis of Gastric Cancer through Inhibiting the BRD4/Snail Signaling Pathway and the Transcriptional Activity of β-Catenin
por: Sun, Chao, et al.
Publicado: (2022)

Enhanced Autophagic Flux, Suppressed Apoptosis and Reduced Macrophage Infiltration by Dasatinib in Kidneys of Obese Mice
por: Elsayed, Hassan Reda Hassan, et al.
Publicado: (2022)

Subcellular Expression Patterns of FKBP Prolyl Isomerase 10 (FKBP10) in Colorectal Cancer and Its Clinical Significance
por: Fu, Yating, et al.
Publicado: (2023)

Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway
por: Li, Hongchun, et al.
Publicado: (2022)

Dasatinib suppresses particulate-induced pyroptosis and acute lung inflammation
por: Pan, Yixi, et al.
Publicado: (2023)

Retracted: DSC2 Suppresses the Metastasis of Gastric Cancer through Inhibiting the BRD4/Snail Signaling Pathway and the Transcriptional Activity of β-Catenin
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib
por: Bradt, Nicolas, et al.
Publicado: (2022)

BRD4 inhibition suppresses cell growth, migration and invasion of salivary adenoid cystic carcinoma
por: Wang, Limei, et al.
Publicado: (2017)

AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells
por: Lin, Cho-Hao, et al.
Publicado: (2022)

Dasatinib inhibits proinflammatory functions of mature human neutrophils
por: Futosi, Krisztina, et al.
Publicado: (2012)

Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells
por: Zhou, Lixin, et al.
Publicado: (2021)

BRD4 Inhibition Protects Against Myocardial Ischemia/Reperfusion Injury by Suppressing Inflammation and Oxidative Stress Through the PI3K/AKT Signaling Pathway
por: Wei, Hongwei, et al.
Publicado: (2021)

Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
por: Zhang, Hao, et al.
Publicado: (2021)

Dasatinib Nanoemulsion and Nanocrystal for Enhanced Oral Drug Delivery
por: Wang, Chuanqi, et al.
Publicado: (2022)

Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib
por: Montenegro, Raquel Carvalho, et al.
Publicado: (2020)

mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL
por: Gotesman, Moran, et al.
Publicado: (2018)

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Pericole, Fernando Vieira, et al.
Publicado: (2019)

MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib
por: Young, Adelaide I. J., et al.
Publicado: (2016)

Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice
por: Lee, Dajeong, et al.
Publicado: (2020)

Inhibition of BRD4 triggers cellular senescence through suppressing aurora kinases in oesophageal cancer cells
por: Xu, Jian‐Ling, et al.
Publicado: (2020)

Dasatinib-Related Chylothorax
por: Huang, Yen-Min, et al.
Publicado: (2015)

DASATINIB-RELATED CHYLOTHORAX
por: Young, Katherine, et al.
Publicado: (2019)

Dasatinib Inhibits Procoagulant and Clot Retracting Activities of Human Platelets
por: Beke Debreceni, Ildikó, et al.
Publicado: (2019)

Activity-Based Protein Profiling Reveals Potential Dasatinib Targets in Gastric Cancer
por: Choi, Kyoung-Min, et al.
Publicado: (2020)

BRD4 inhibition for the treatment of pathological organ fibrosis
por: Stratton, Matthew S., et al.
Publicado: (2017)

Inhibiting BRD4 to generate BETter T cell memory
por: Kasmani, Moujtaba Y., et al.
Publicado: (2021)

Unexpected BrdU inhibition on astrocyte-to-neuron conversion
por: Wang, Tao, et al.
Publicado: (2021)

Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction
por: Yin, Mingzhu, et al.
Publicado: (2020)

BRD4 inhibition promotes TRAIL-induced apoptosis by suppressing the transcriptional activity of NF-κB in NSCLC
por: Shi, Liu, et al.
Publicado: (2021)

Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
por: Hügle, Martin, et al.
Publicado: (2016)

Inhibition of BRD4 inhibits proliferation and promotes apoptosis of psoriatic keratinocytes
por: Sun, Xiaohui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4mgqbkto2man12rvl1pi6cvplh